Gamma Wave Therapy for Traumatic Brain Injury
(DAGABBI Trial)
Trial Summary
What is the purpose of this trial?
Combat Veterans of post-9/11 conflicts have experienced serious cognitive and emotional problems resulting from exposure to blasts. Recent work suggests that a critical factor influencing the consequences of blast exposure is distance from the blast, rather than the presence or absence of concussion symptoms. Exposure to blasts from a distance of \<10 m has been associated with significantly greater cognitive and neural problems than exposure to blasts from \>10 m. So far, the effects of blast-related brain injury on the brain are poorly understood, as to date the effects of blast exposure have received little research focus. The investigators propose to use oscillations in the gamma band (30-100 Hz) of the electroencephalogram (EEG; brain waves) to detect and remediate neural circuit dysfunction related to blast injury in Veterans. If successful, this project could lead to new approaches to detect and remediate the effects of blast exposure on Veterans and aid in their functional recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Auditory gamma sensory stimulation for Traumatic Brain Injury?
Research shows that gamma-band auditory stimulation, particularly at 60 Hz, may improve certain cognitive functions like executive functions in healthy adults. Additionally, structured auditory sensory stimulation programs have shown positive recovery outcomes in patients with severe traumatic brain injury, suggesting potential benefits of auditory stimulation in this context.12345
Is Gamma Wave Therapy safe for humans?
How does Gamma Wave Therapy differ from other treatments for traumatic brain injury?
Gamma Wave Therapy is unique because it uses transcranial alternating current stimulation (tACS) to specifically target gamma brain waves, which are involved in brain functions like memory and attention. This approach is different from traditional treatments as it aims to modulate brain activity non-invasively by synchronizing and enhancing gamma oscillations, potentially improving cognitive functions affected by traumatic brain injury.1261112
Research Team
Kevin M. Spencer, PhD
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Eligibility Criteria
This trial is for post-9/11 combat veterans aged 18-65 who have experienced blast exposure and are part of the VA Boston Healthcare System. It includes those exposed to blasts from less than or more than 10 meters away, with groups matched by age and gender. Veterans must not have severe mental health issues, neurological illnesses, substance abuse problems, or hearing impairments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive auditory gamma sensory stimulation to assess and remediate gamma oscillation abnormalities
Follow-up
Participants are monitored for changes in gamma power and cognitive function after treatment
Treatment Details
Interventions
- Auditory gamma sensory stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor